METHOD FOR FABRICATION OF MICROWELLS FOR CONTROLLED FORMATION OF 3-DIMENSIONAL MULTICELLULAR-SHAPES
20170283766 · 2017-10-05
Inventors
- Kolin C. Hribar (La Jolla, CA)
- Shaochen Chen (San Diego, CA)
- Darren Finlay (La Jolla, CA)
- Kristiina Vuori (La Jolla, CA)
- Xuanyi Ma (La Jolla, CA)
Cpc classification
B33Y10/00
PERFORMING OPERATIONS; TRANSPORTING
B29C64/129
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/12
PERFORMING OPERATIONS; TRANSPORTING
B29C64/135
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0893
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0829
PERFORMING OPERATIONS; TRANSPORTING
B01L3/5085
PERFORMING OPERATIONS; TRANSPORTING
B29C64/124
PERFORMING OPERATIONS; TRANSPORTING
C12M33/00
CHEMISTRY; METALLURGY
C12N5/0062
CHEMISTRY; METALLURGY
C12N5/0696
CHEMISTRY; METALLURGY
International classification
C12N5/00
CHEMISTRY; METALLURGY
B29C67/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
Using 3D printing, a microwell is formed by providing a plurality of masks, each mask representing a cross-section of a layer of the concave structure. Progressive movement of a projection plane exposes a pre-polymer solution to polymerizing radiation modulated by the masks to define the layers of the microwell, where each layer is exposed for a non-equal exposure period as determined by a non-linear factor. In a preferred embodiment, a first portion of the masks are base layer masks, which are exposed for a longer period than subsequent exposure periods. Shapes of the microwells, which may include circular, square, annular, or other geometric shapes, and their depths, are selected to promote aggregation behavior in the target cells, which may include tumor cells and stem cells.
Claims
1. A method for three-dimensional printing of a concave structure, comprising: providing a plurality of masks, each mask representing a cross-section of a layer of the concave structure; and progressively moving a projection plane to expose a pre-polymer solution to a polymerizing radiation source modulated by the plurality of masks to define the plurality of layers of the concave structure, wherein each layer is exposed for an exposure period within a total exposure time, wherein the exposure periods are non-equal portions of the total exposure time.
2. The method of claim 1, wherein a first portion of the plurality of masks comprises base layer masks, wherein a first exposure period for the first portion is longer than subsequent exposure periods.
3. The method of claim 2, wherein the total exposure time is determined according to the relationship T.sub.0+T.sub.0*(1+L.sub.i*A.sub.2).sup.2, where T.sub.0 is the first exposure period, L.sub.i is a layer number of a layer of the plurality of layers, and A.sub.2 is a non-linear factor.
4. The method of claim 3, wherein the non-linear factor A.sub.2 is within a range of −0.025 to 0.
5. The method of claim 3, wherein the first exposure period T.sub.0 is within a range of 0.5 second to 1 second.
6. The method of claim 3, wherein the non-linear factor A.sub.2 is −0.023 and the first exposure period T.sub.0 is 0.95.
7. The method of claim 3, wherein the total exposure time is within a range of 10 seconds to 30 seconds.
8. The method of claim 1, wherein the pre-polymer solution is PEGDA.
9. The method of claim 1, wherein the step of progressively moving comprises moving a stage supporting a container containing the pre-polymer solution along a z-axis relative to the polymerizing radiation source.
10. The method of claim 1, wherein the stage is moved at non-equal time increments corresponding to the exposure periods.
11. The method of claim 1, wherein the plurality of masks is configured for defining to an array of circular patterns of progressively increasing diameter from a bottom of the concave structure to a top of the concave structure.
12. The method of claim 2, wherein a first portion of the plurality of masks comprises no pattern, so that the entire pre-polymer solution is exposed to polymerizing radiation.
13. The method of claim 1, wherein the concave structure has a shape selected from circular, oval, square, rectangular, annular, polygonal, and other geometric shapes.
14. The method of claim 1, wherein the concave structure is optically clear.
15.-27. (canceled)
28. A method for forming multicellular clusters, comprising: providing at least one microwell comprising: providing a plurality of masks, each mask representing a cross-section of a layer of the concave structure; and progressively moving a projection plane to expose a pre-polymer solution to a polymerizing radiation source modulated by the plurality of masks to define the plurality of layers of the concave structure, wherein each layer is exposed for an exposure period within a total exposure time, wherein the exposure periods are non-equal portions of the total exposure time; seeding from 100 k to 750 k cells in the at least one microwell; and aggregating the cells in the at least one microwell.
29. The method of claim 28, wherein the cells are iPSCs.
30. The method of claim 28, wherein the cells are tumor cells.
31. (canceled)
32. The method of claim 28, wherein the total exposure time is determined according to the relationship T.sub.0+T.sub.0*(1+L.sub.i*A.sub.2).sup.2, where T.sub.0 is the first exposure period, L.sub.i is a layer number of a layer of the plurality of layers, and A.sub.2 is a non-linear factor.
33. The method of claim 31, wherein the non-linear factor A.sub.2 is within a range of −0.025 to 0.
34. The method of claim 31, wherein the first exposure period T.sub.0 is within a range of 0.5 second to 1 second.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
DETAILED DESCRIPTION
[0042] The proposed 3D printing technology utilizes continuous 3D printing of a series of layers using an automated stage. While similar 3D printing systems have been previously disclosed (see, e.g., International Publication No. WO2014/197622, and International Publication No. WO2012/071477, which are incorporated herein by reference), the present invention provides an important modification that uses non-linear UV light exposure, i.e., non-linear projection optical printing (nPOP), to enable precise control of the polymerization for formation of optimal structures for cell culture.
[0043] According to the exemplary embodiments, a method for three-dimensional printing of a concave structure comprises providing a plurality of masks, each mask representing a cross-section of a layer of the concave structure. Progressively moving a projection plane exposes a pre-polymer solution to a polymerizing radiation source modulated by the plurality of masks to define the plurality of layers of the concave structure, wherein each layer is exposed for an exposure period within a total exposure time, wherein the exposure periods are non-equal portions of the total exposure time as determined by a non-linear factor. In a preferred embodiment, a first portion of the plurality of masks comprises base layer masks, wherein a first exposure period for the first portion is longer than subsequent exposure periods.
[0044] The basic elements of a 3D printing platform 100 for use in an exemplary embodiment of the invention are illustrated in
[0045] As an alternative to the DMD chip, a galvanometer optical scanner or a polygon scanning mirror, may be used. Both of these technologies, which are commercially available, are known in their application to high speed scanning confocal microscopy. Selection of an appropriate scanning mechanism for use in conjunction with the inventive system and method will be within the level of skill in the art.
[0046] As shown in
[0047] Panel II of
[0048] In the described embodiment, we used a circular microwell pattern (500 μm in diameter) with a gradient pattern and applied 53 layers to the image.
[0049]
[0050] The microwell is built in a continuous layer-by-layer fashion, alongside a continuously moving z-stage that coordinates its movements in the z direction with changes in the optical masks. The layer numbers and relative blocking mask shapes and sizes are provided as examples only. In addition to circles, mask shapes (and the microwells printed therefrom) may also include oval, square, rectangular, annular (ring), polygonal, and other geometric shapes depending on the desired aggregation behavior. It will be readily apparent to those in the art that selection of shapes, the number of the layers and progression of blocking mask dimensions will depend on parameters appropriate for the intended application.
[0051] Setting the z-height to 500 μm, for the example of 53 layers, the stage moves 9.4 μm for each layer, continuously changing the projection plane within the prepolymer solution as it moves through the layering sequence. Importantly, the nPOP technology permits the creation of any complex and precisely-defined concave structure simply by changing the design or gradient of the input pattern. A few examples of these designs are provided in
[0052] Evaluation of the microwells included SEM images of the samples. In each case, preparation of the microwell samples for SEM imaging involved freeze-drying the samples in a glass vial exposed to isopropanol in dry ice, and lyophilizing overnight. Samples were then coated with iridium and imaged using an FEI SFEG Ultra-high resolution SEM.
[0053] In a preferred embodiment, the prepolymer solution used to fabricate the microwells is 20% (w/v) poly(ethylene glycol) (PEG) diacrylate (DA). PEG is an FDA-approved biomaterial and often utilized in cell culture because of its many useful qualities for biomedical applications, including low immunogenicity, high water retention, biocompatibility, minimal protein adsorption, tunability, and optical clarity. An additional advantage of this material selection is that PEG acts as a non-adhering material, thus assisting in the limitation of cell-material interaction and promoting cell clustering. Other materials that may be used include GelMA (gelatin methacrylate), HA (hyaluronic acid), and other hydrogels and polymers that exhibit the qualities needed for cell culture.
[0054] For testing, (PEGDA) (MW 700, Sigma), 0.05% Irgacure 2959 (Ciba) in phosphate buffer saline (PBS) was administered between two glass slides and exposed to 15 mW/cm2 UV light source (Omnicure S2000, 365 nm) using dynamic optical projection stereolithography setup.
[0055] UV photopolymerization and gelation of PEGDA is a non-linear process, where free radical initiation, polymer chain propagation, and termination take place on multi-order kinetics. Thus, the 3D printing process according to one embodiment of the invention allows for nonlinear UV exposure. In our layer-by-layer nPOP fabrication setup, non-linear UV exposure for a series of layers is controlled by the following equation:
Total exposure time (T.sub.total)=T.sub.0+T.sub.0*(1+L.sub.i*A.sub.2).sup.2, (1)
where T.sub.0 is the exposure time for the base layer, L.sub.i is the layer number, and A.sub.2 is the non-linear factor. Total exposure time is the aggregate exposure for all the layers. For purposes of this evaluation, to build a microwell of about 1 mm in both depth and upper diameter, we looked at total exposure times within a range of about 10 seconds to 30 seconds, base layer exposure times within a range of around 0.5 to 1 second, with a non-linear factor A.sub.2 within a range of about −0.025 to 0.
[0056] Based on the exposure time and selected height, the software adjusts the speed of the automated stage. For initial testing, the z-height for all structures was held constant at 500 μm. Microwells were polymerized onto glass coverslips pretreated with the chemical modification of 3-(Trimethoxysilyl)-Propyl Methacrylate (TMSPMA). After fabrication, the microwells were washed three times in PBS over the course of two days.
[0057]
[0058] The horizontal arrows in each of the five panels (i-v) correspond to exposure time from left to right. The vertical arrows compares initial exposure time T.sub.0 for the base layer. At lower values of T.sub.0, e.g., panels i and ii of
[0059]
[0060] After optimizing the fabrication parameters, microwells with T.sub.0 and A.sub.2 values of 0.95 seconds and −0.023, respectively (total exposure time ˜14.4 s) were used for the remainder of the experiments. Scanning electron microscopy was used to confirm the 3D shape of the microwells, shown in
[0061] As an extension of the platform's versatility in microwell design, we showed the fabrication of microwells with concave or flat shapes while maintaining the same fabrication parameters, but varying the number of layers in the base layer (15, 24 and 34), such that the total exposure time for the base layers—varied while the total exposure time remained constant at 14.4 seconds. Three different variations are illustrated in
[0062] Atomic force microscopy (AFM; MFP3D, Asylum Research) was used to assess the stiffness profile on the microwell surface of Gradient 1 (
[0063] The microwell displayed a soft center (10 Pa) and stiffened to ˜200 Pa on the edge of the well, before reaching the stiffer wall (˜1-2 kPa). Values plotted in
[0064] We hypothesized that the soft center correlates to earlier layers of UV exposure during the fabrication process, and as it proceeds through the layers, increasing UV exposure drives additional crosslinking to stiffen the microwell. This was confirmed by taking stiffness measurements of flat microwells formed with different UV exposures to the base (according to
[0065] To evaluate whether non-linear exposure is, indeed, necessary to create the concave microwells useful for 3D cell culture, the same fabrication timeframe used for the aforementioned microwells was used in a non-linear exposure sequence: the total number of base layers were exposed for 10.2 seconds and the remaining layers were exposed for 4.2 seconds. For linear exposure of 75 total layers (50 base), this would require a T.sub.0 value of 0.192 according to Equation 1 (and A.sub.2=0). The exposure parameters and a SEM micrograph of the resulting microwells are shown in
[0066]
[0067]
[0068] Expanding on the initial cell experiments, BT474 breast cancer cells were seeded at various densities and used to assess spheroid generation and growth within the microwells, as shown in the SEM images of
[0069] At day 2, cell seeding densities of 250 k, 500 k, and 750 k cells mL.sup.−1 produced spheroids with diameters 146±11 μm, 194±30 μm, and 213±16 μm, respectively (
[0070] Over the course of several days following seeding, spheroids from the higher cell densities began to plateau at a size of around 250-275 μm, while the smaller spheroids with an initial density of 250 k mL.sup.−1 continued to grow in size, albeit smaller than the 250 μm threshold. Growth rates for each group confirmed this trend, as shown in the inset in
[0071] Interestingly, live/dead staining with calcein AM/ethidium homodimer showed considerable cell death in the 500 and 750 K mL.sup.−1 seeding densities compared to the lower 250 K mL.sup.−1 at day 10. This observation could be indicative of a necrotic core forming for these initially larger spheroids, correlating with regression in spheroid growth. It has been well documented that tumor spheroids greater than ˜200 μm in diameter demonstrate a hypoxic core due to a nutrient and gas transport gradient, which in turn can lead to necrosis. The presence of a hypoxic core in the tumor spheroid provides a more physiologically relevant tumor model for cancer screening applications, since tumor hypoxia in vivo often drives angiogenesis. Hypoxia was confirmed with immunostaining of the spheroid cross-sections using HIF-1α, a biomarker for hypoxia (
[0072] The foregoing data are in good agreement with previous literature regarding tumor spheroid progression (e.g., hypoxia and necrosis). Furthermore, they support our earlier observation that cell death increases with increasing cell seeding densities.
[0073] Referring to
[0074] Human perinatal foreskin fibroblasts (BJ, ATCC) and human adult dermal fibroblasts (HDF, Cell Applications) were maintained in DMEM (Corning) supplemented with 10% Fetal Bovine Serum (Tissue Culture Biologicals) and Antibiotics/Antimicotic (Corning) in a 37° C., 5% CO.sub.2 incubator. Cells were passaged at a ratio of 1:6 every 3-5 days by 0.25% Trypsin-EDTA (Corning) before reprogramming T.sub.0 prepare for reprogramming, fibroblasts were seeded at a density of 2×10.sup.5 cells/well in 6-well plates, and allowed to attach and spread for 48 h. Reprogramming was performed following the instructions in a Sendai virus-based CYTOTUNE® iPS reprogramming kit (Life Technologies) for the delivery of four factors Oct4, Sox2, Klf4 and c-Myc.
[0075] Following successful reprogramming, growth factor reduced MATRIGEL® (BD Biosciences, N.J., USA) was used as the substrate for the maintenance of the iPSCs culture in serum- and feeder-free conditioned medium (StemPro®, Life Technologies) following the manufacturer's instructions. Cells were split at a ratio of 1:6 every 3-4 days by VERSENE® (Life Technologies) before experiments.
[0076] Similar to the cancer cell seeding protocol, microwells were sterilized under UV irradiation for 1 hour. Human iPSCs at 70-80% confluency were detached by ACCUTASE® cell detachment solution (Innovative Cell Technologies) and re-suspended in regular culture medium with 5 uM ROCK (Rho-associated kinase) inhibitor Y27632 (STEMGENT®). Cells were seeded at a concentration of 100 k or 400 k per milliliter into each of the well with microwell construct. The plates were spun at a speed of 210 rcf for 5 minutes and then incubated in a 37° C., 5% CO.sub.2 incubator for 24 hours. Maintenance medium was replaced every day.
[0077] iPSCs were seeded on top of the microwells at varying cell densities (either 100 k or 400 k cells mL.sup.−1) and imaged over three days. Embryoid bodies (EBs) were fixed in 4% paraformaldehyde in PBS three days following seeding. They were subsequently permeabilized with 0.1% Triton X-100 in PBS and incubated with antibodies against Oct4 (Cell Signaling Technology) and Nanog (Cell Signaling Technology) followed by fluorophore-conjugated anti-IgG antibodies. DAPI (Invitrogen) nucleus counterstain was also performed. For differentiation studies, EBs were grown in the same manner in the inventive microwells at varying concentrations (100 k or 400 k cells mL.sup.−1) for 10 days, followed by fixing and immunostaining with biomarkers for the three germ layers: SOX-1 for ectoderm, SOX-17 for endoderm, and Brachyury for mesoderm (R&D Systems). Images were taken using a Leica fluorescence microscope and an Olympus confocal microscope.
[0078] Single EBs could be formed in the concave wells after three days in proportion to the seeding density (
[0079] At day 10, EBs displayed morphological changes in their size, shape, and appearance in the form of intra-organoid cavities, as shown in
[0080] Using the inventive non-linear projection optical printing (nPOP) technology, microwells of various sizes and shapes were developed to control the 3D PSC aggregate shapes in vitro. Microwells of circular, square and ring shapes of 500 μm in thickness were printed using the nPOP platform for controlling aggregation of both human induced pluripotent stem cells (iPSCs) and mouse embryonic stem cells. As shown in the brightfield images of
[0081] Based on these results, the nPOP technology can facilitate EB formation and culture maintenance, demonstrating pluripotency at early time points as well as differentiation at later time points, making it a potential tool for understanding early embryonic development at large.
[0082] 3D cell culture has a high potential to improve drug screening validation practices and enhance tissue engineering and stem cell fields, however the current methodologies for cluster generation are labor intensive, sometimes non-optically clear, uncontrolled, or require plate transfer. There is thus, a pressing need to create reproducibly sized spheroids on an optically-clear, non-adhering, low protein absorption substrate for the formation of multicellular clusters.
[0083] The PEG microwells fabricated using the nPOP printing methods described herein provide the precisely controlled concavities needed for controlled cell culture. These microwells represent a significant enhancement over current technologies that often require spheroid transfer upon formation and full saturation of the wells. This novel approach will enable others to perform various 3D cellular assays with controlled ease of growing and maintaining spheroids without the need for spheroid transfer, and can greatly impact drug screening, tissue engineering and the 3D bioprinting fields in general. Furthermore, the ability to generate consistently sized tumors of physiologically relevant sizes (greater than >600 microns in diameter), opens the door to exploring more fundamental cancer biology questions, such as migration and metastasis.
[0084] The following publications are incorporated herein by reference to the extent that they teach the general state of the art to facilitate understanding of the present invention: [0085] 1. Derby, B., “Printing and prototyping of tissues and scaffolds,” Science 338, 921-926 (2012). [0086] 2. Ungrin, M. D., Joshi, C., Nica, A., Bauwens, C. & Zandstra, P. W. “Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates,” PloS One 3, e1565 (2008). [0087] 3. Huh, D., Hamilton, G. A. & Ingber, D. E., “From 3D cell culture to organs-on-chips,” Trends in Cell Biology 21, 745-754 (2011). [0088] 4. Lee, M. Y. et al., “Three-dimensional cellular microarray for high-throughput toxicology assays,” PNAS 105, 59-63 (2008). [0089] 5. Elliott, N. T. & Yuan, F., “A review of three-dimensional in vitro tissue models for drug discovery and transport studies,” J. Pharmaceutical Sciences 100, 59-74 (2011). [0090] 6. Pampaloni, F., Reynaud, E. G. & Stelzer, E. H., “The third dimension bridges the gap between cell culture and live tissue,” Nature Reviews Molecular Cell Biology 8, 839-845 (2007). [0091] 7. Hribar, K. C., Soman, P., Warner, J., Chung, P. & Chen, S., “Light-assisted direct-write of 3D functional biomaterials,” Lab on a Chip 14, 268-275 (2014). [0092] 8. Debnath, J. & Brugge, J. S., “Modelling glandular epithelial cancers in three-dimensional cultures,” Nature Reviews Cancer 5, 675-688 (2005). [0093] 9. Karp, J. M. et al., “Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells,” Lab on a Chip 7, 786-794 (2007). [0094] 10. Hwang, Y. S. et al., “Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNTSa and WNT11,” PNAS 106, 16978-16983 (2009). [0095] 11. Choi, Y. Y. et al., “Controlled-size embryoid body formation in concave microwell arrays,” Biomaterials 31, 4296-4303 (2010). [0096] 12. Itskovitz-Eldor, J. et al., “Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers,” Molecular Medicine 6, 88-95 (2000). [0097] 13. Spence, J. R. et al., “Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro,” Nature 470, 105-109 (2011). [0098] 14. Laib, A. M. et al., “Spheroid-based human endothelial cell microvessel formation in vivo,” Nature Protocols 4, 1202-1215 (2009). [0099] 15. Kelm, J. M. et al., “Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units,” Tissue engineering 12, 2151-2160 (2006). [0100] 16. Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A., “Spheroid-based drug screen: considerations and practical approach,” Nature Protocols 4, 309-324 (2009). [0101] 17. Hirschhaeuser, F. et al., “Multicellular tumor spheroids: an underestimated tool is catching up again,” J. Biotechnology 148, 3-15 (2010). [0102] 18. Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F. & Ebner, R., “The use of 3-D cultures for high-throughput screening: the multicellular spheroid model,” J. Biomolecular Screening 9, 273-285 (2004). [0103] 19. Fukuda, J. & Nakazawa, K., “Orderly arrangement of hepatocyte spheroids on a microfabricated chip. Tissue engineering 11, 1254-1262 (2005). [0104] 20. Thoma, C. R. et al. A high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi screening applications,” J. Biomolecular Screening 18, 1330-1337 (2013). [0105] 21. Moeller, H. C., Mian, M. K., Shrivastava, S., Chung, B. G. & Khademhosseini, A., “A microwell array system for stem cell culture,” Biomaterials 29, 752-763 (2008). [0106] 22. Toepke, M. W. & Beebe, D. J., “PDMS absorption of small molecules and consequences in microfluidic applications,” Lab on a Chip 6, 1484-1486 (2006). [0107] 23. Peppas, N. A., Hilt, J. Z., Khademhosseini, A. & Langer, R., “Hydrogels in Biology and Medicine: From Molecular Principles to Biotechnology,” Adv. Mater. 18, 1345-1360 (2006). [0108] 24. Kizilel, S., Perez-Luna, V. H. & Teymour, F., “Mathematical model for surface-initiated photopolymerization of poly(ethylene glycol) diacrylate,” Macromol. Theor. Simul 15, 686-700 (2006). [0109] 25. Takahashi, K. et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell 131, 861-872 (2007). [0110] 26. Choi, Y. S. et al., “The alignment and fusion assembly of adipose-derived stem cells on mechanically patterned matrices,” Biomaterials 33, 6943-6951 (2012). [0111] 27. Radmacher, M., “Studying the mechanics of cellular processes by atomic force microscopy,” Method Cell Biol 83, 347-372 (2007).